Cellular senescence in the cholangiopathies

Pamela S. Bogert, Steven P. O'Hara, Nicholas F. Larusso

Research output: Contribution to journalReview articlepeer-review


Purpose of reviewCellular senescence (i.e. permanent withdrawal from the cell cycle) is increasingly recognized as a pathologic feature in a variety of inflammatory liver diseases, including primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC) and additional cholangiopathies. Herein, we provide an update on the interplay between cholangiocytes, cellular senescence and the cholangiopathies.Recent findingsThe themes covered by this review include novel models for studying the role of senescent cholangiocytes and the cholangiopathies, identification and modulation of key pathways or molecules regulating cholangiocyte senescence, and discovery of druggable targets to advance therapeutic options for the cholangiopathies. Most recent studies focused on PSC; however, the concepts and findings may be applied to additional cholangiopathies.SummaryCholangiopathies present unique and divergent clinicopathological features, causes and genetic backgrounds, but share several common disease processes. Cholangiocyte senescence in the cholestatic cholangiopathies, primarily PSC and PBC, is regarded as a key pathogenetic process. Importantly, senescent cholangiocytes exhibit phenotypic features including the senescence-associated secretory phenotype (SASP) and resistance to apoptosis that provide new directions for basic research and new prognostic and therapeutic approaches for clinical practice.

Original languageEnglish (US)
Pages (from-to)121-127
Number of pages7
JournalCurrent Opinion in Gastroenterology
Issue number2
StatePublished - Mar 1 2022


  • apoptosis resistance
  • cellular senescence
  • cholangiopathies
  • senescence-associated secretory phenotype

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Cellular senescence in the cholangiopathies'. Together they form a unique fingerprint.

Cite this